Connect with us
European Gaming Congress 2024

Artificial Intelligence

New to The Street TV Announces Its 5 Business Guest Interviews Being Broadcasted on Bloomberg TV, Saturday, August 7, 2021 at 4:30 PM ET

Published

on

NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) — FMW Media’s New to The Street TV announces the broadcasting of its business TV show, Saturday, August 7, 2021 on Bloomberg TV at 4:30 PM ET.

New to The Street’s TV line-up features the following 5-Companies and their businesses representatives:

1). Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) interview with Mr. Seth Lederman, CEO

2). Artificial Intelligence Technology Solutions, Inc.’s (OTCPink:AITX) interview with Steven Reinharz, CEO.

3) RushNet, Inc.’s (a.k.a – heliosDX) (OTCPink: RSHN) interview with Ashley Sweat, Chief Executive Officer / Chairman.

4). GlobeX Data Ltd’s. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) interview with Mr. Alain Ghiai, CEO.

Advertisement
Stake.com

5) First Graphene Ltd.’s (OTCQB:FGPHF) interview with Mr. Michael Bell, CEO.

Tonix Pharmaceuticals, Inc.’s (NASDAQ:TNXP) CEO, Seth Lederman, talks to New To The StreetTV about their Company’s pharmaceutical products, and he leads a further in-depth discussion about their development and FDA phase 3 trial on its Fibromyalgia drug. Mr. Lederman talks about the importance of ‘HOW’ their Fibromyalgia drug helps patients sleep better without pain. 

New to the Street TV show interviews Mr. Steven Reinharz, CEO at Artificial Intelligence Technology Solutions, Inc. (OTCPink: AITX) who talks to viewers about the Company and its wholly-owned subsidiary, Robotic Assistance Devices, Inc. (RAD). He gives very detailed description of its AI-driven security analytical product, ROSA 180 (Responsive Observation Security Agent). Mr. Reinharz provides numerous real use applications and its successful roll-outs as a less expensive and efficient security solution for a number of industries.

Ashely Sweat, CEO at RushNet, Inc.’s (a.k.a – heliosDX) (OTCPink: RSHN) joins the New to The Street show. Mr. Sweat explains RushNet, Inc.’s. (heliosDX) very sophisticated and technological advanced clinical laboratory, which can provide highly accurate tests for a variety of different medical and clinical needs. Further, he outlines RSHN’s business model and the expected growth associated with their lab platforms and its uniqueness in the clinical lab industry sector.

Once again on New to The Street TV, Mr. Alain Ghiai, CEO, GlobeX Data, Ltd (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) who gives more pivotal information to viewers about their business and their plans to grow the Company. As an international acclaimed expert in internet security and privacy, he provides in-depth discussion of the Company’s successful growth of its secure and encrypted software solutions, SekurSafe® and Sekur®. Alain reminds the viewers that GlobeX Data NEVER sells data to third-parties. He gives very specific and interesting dialog about keeping their clients’ business communications and data safe while utilizing Swiss Privacy Laws.

Advertisement
Stake.com

New to The Street welcomes to the show Mr. Michael Bell, CEO, First Graphene Ltd (OTCQB:FGPHF). Mr. Bell explains the Company’s operations and graphene products. He talks about PureGRAPH® as being recognized as a world leading graphene product brand. Mr. Bell continues the interview with a discussion about their graphene production, mining tonnage projections, and the newly adoption of graphene in a variety of products used worldwide.

About Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP):

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric and addiction conditions. Tonix’s lead CNS candidate, TNX-102 SL1, is in mid-Phase 3 developments for the management of fibromyalgia, and positive data on the RELIEF Phase 3 trial were recently reported. The Company expects interim data from a second Phase 3 study, RALLY, in the third quarter of 20212 and top-line data in the fourth quarter of 2021. The immunology portfolio includes vaccines to prevent infectious diseases and biologics to address immunosuppression, cancer, and autoimmune diseases. Tonix’s lead vaccine candidate, TNX-18003, is a live replicating vaccine based on the horsepox viral vector platform to protect against COVID-19, primarily by eliciting a T cell response. Tonix reported positive efficacy data from animal studies of TNX-1800 in the first quarter of 2021. TNX-801, live horsepox virus vaccine for percutaneous administration, is in development to protect against smallpox and monkeypox – www.tonixpharma.com.

1TNX-102 SL is an investigational new drug and has not been approved for any indication.
2Pending agreement from FDA on statistical analysis plan

About Artificial Intelligence Technology Solutions (OTCPink:AITX):

Advertisement
Stake.com

AITX is an innovator in the delivery of artificial intelligence-based solutions that empower organizations to gain new insight, solve complex challenges and fuel new business ideas. Through its next-generation robotic product offerings, AITX’s RAD and RAD-M companies help organizations streamline operations, increase ROI and strengthen business. AITX technology improves the simplicity and economics of patrolling and guard services, and allows experienced personnel to focus on more strategic tasks. Customers augment the capabilities of existing staffs and gain higher levels of situational awareness, all at drastically reduced cost. AITX solutions are well suited for use in multiple industries such as enterprises, government, transportation, critical infrastructure, education and healthcare. To learn more, visit www.aitx.ai and www.roboticassistancedevices.com, or follow Steve Reinharz on Twitter @SteveReinharz.

About HeliosDx (RushNet, Inc) (OTCPink: RSHN):

heliosDX (OTCPink: RSHN) is a National Clinical Reference Laboratory offering High-Complexity Urine Drug Testing (UDT), Behavioral Drug Testing, Allergy Droplet Cards, Oral Fluids, Infectious Disease (PCR), and NGS Genetic Testing. The Company is contracted in 44 of the lower 48 states, and looking to expand its reach and capabilities. The Company continually invests in its infrastructure with the most efficient scientific proven instruments, and latest cutting-edge software for patient and physician satisfaction. This allows heliosDX to provide physicians fast and accurate reporting meeting and exceeding industry benchmarks. heliosDX excels in patient and client care through physician designed panels that aid in testing compliance and reporting education- https://heliosdx.com/.

About GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT):

GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) (FRA:GDT) is a Cybersecurity and Internet Privacy provider of Swiss hosted solutions for secure communications and secure data management. The Company distributes a suite of secure messaging applications, encrypted e-mails, secure communications and secure data management tools, using Swiss privacy laws, proprietary technology and its own independent platform, away from big tech’s hosting platforms. GlobeX Data Ltd. sells its products through its approved wholesalers and distributors, and telecommunications companies worldwide. GlobeX Data Ltd. serves consumers, businesses and governments worldwide – https://globexdata.com. Sekur® is a Swiss secure communications application offering secure and private messaging, emails, voice messages, self-deleting messages, and file transfers from any mobile device, tablet, or desktop. Sekur users can communicate with Sekur and with non-Sekur users, through its unique Chat-By-Invites feature and SekurSend email system. All data traffic stay in GlobeX Data’s Swiss hosted servers, using its proprietary HeliX technology, military grade encryption and benefiting from Swiss Privacy Laws – https://sekur.com. Twitter: @globexdata.

Advertisement
Stake.com

About First Graphene Ltd (OTCQB: FGPHF) (ASX: FGR):

First Graphene Ltd (OTCQB: FGPHF) (ASX: FGR) is the leading supplier of high-performing, graphene products. The company has a robust manufacturing platform based upon captive supply of high-purity raw materials and an established 100 tonne/year graphene production capacity. Commercial applications are now being progressed in composites, elastomers, fire retardancy, construction and energy storage. PureGRAPH® Range of Products PureGRAPH® graphene powders are available in tonnage volumes with lateral platelet sizes of 50μm, 20μm, 10μm and 5μm. The products are high performing additives, characterized by their high quality and ease of use. First Graphene Ltd. is publicly listed on the OTC MARKETS (OTCQB: FGPHF) and on the Australia Stock Exchange (ASX:FGR).

About FMW Media:

FMW Media operates one of the longest-running U.S and International sponsored and Syndicated Nielsen Rated programming T.V. brands “New to the Street,” and its blockchain show “Exploring The Block.” Since 2009, these brands run biographical interview segment shows across major U.S. Television networks. The TV platforms reach over 540 million homes both in the US and international markets. FMW recently added Newsmax to its broadcasting platform with its first show broadcasted Sunday, December 27th. The NEWSMAX New to The Street show is syndicated on Sundays at 10 AM EST. FMW is also one of the nation’s largest buyers of linear Television long and short form- https://www.newsmaxtv.com/Shows/New-to-the-Street
https://www.newtothestreet.com/.

Forward-Looking Statements Disclaimer:

Advertisement
Stake.com

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. In some cases, you can identify forward-looking statements by the following words: “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “ongoing,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would,” or the negative of these terms or other comparable terminology, although not all forward-looking statements contain these words. Forward-looking statements are not a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which such performance or results achieved. This press release should be considered in light of all filings of the Company contained in the Edgar Archives of the Securities and Exchange Commission at www.sec.gov.

FMW Media Contact:
Bryan Johnson
+1 (631) 766-7462
[email protected]

And
“New to The Street” Business Development office
[email protected]
1-516-696-5900

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/badafbbc-ae53-4caa-b7d6-9ece173d0365

 

Advertisement
Stake.com

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

KMS Lighthouse and lastminute.com Triumph with a Double Win at the Global Sourcing Association (GSA) 2024 Awards

Published

on

kms-lighthouse-and-lastminute.com-triumph-with-a-double-win-at-the-global-sourcing-association-(gsa)-2024-awards

TEL AVIV, Israel, June 17, 2024 /PRNewswire/ — KMS Lighthouse, a global leader in knowledge management, is proud to announce its remarkable achievement of winning two prestigious awards with lastminute.com at the Global Sourcing Association (GSA) 2024 Awards. The brands were honored in the following categories:

Retail Programme of the Year: lastminute.com and KMS Lighthouse LimitedTechnology Enabled Programme of the Year (Automation/AI): lastminute.com and KMS Lighthouse LimitedKMS Lighthouse was also a finalist in the Service Provider of the Year category.
The awards were presented on June 11, 2024, at a glittering ceremony held at Richmond Hill Hotel, as part of the GSA Festival of Sourcing. Celebrating its 21st year, the GSA Awards recognize organizations that demonstrate exceptional best practices in strategic sourcing.
Sagi Eliyahu, CEO of KMS Lighthouse Limited commented “We are absolutely delighted to have won these two esteemed awards. This recognition underscores the tireless dedication and innovation of our teams in delivering exceptional knowledge management solutions to our clients. I would like to extend my heartfelt gratitude to our partners at lastminute.com. The synergy and true partnership we have formed exemplify the collaborative spirit needed to drive outstanding results.”
“We are thrilled to celebrate these award wins with KMS Lighthouse,” said Walter Di Lello, Knowledge Manager & Procedure Team Leader at lastminute.com. “This achievement is a testament to the hard work and dedication of both our teams. The collaborative partnership approach we have fostered with KMS Lighthouse has been pivotal in delivering innovative and impactful solutions. Thank you to everyone involved for their relentless commitment and excellence.”
This double accolade highlights KMS Lighthouse’s unwavering commitment to excellence, innovation, and effective collaboration. The successful partnership with lastminute.com has not only enhanced the retail sector’s capabilities but also set new standards in automation and AI-driven solutions.
About KMS Lighthouse:
KMS Lighthouse is a global leader in knowledge management solutions, providing innovative platforms that enhance organizational knowledge sharing and decision-making. Through advanced AI and automation technologies, KMS Lighthouse enables businesses to improve customer service, streamline operations, and achieve higher efficiency.
About lastminute.com
lastminute.com is the European Travel-Tech leader in Dynamic Holiday Packages. Our mission is to simplify, personalise, and enhance our customers’ travel experience by leveraging technology. Thanks to the iconic brand lastminute.com and a rich portfolio of vertical brands, we meet the most diverse needs of travellers across the entire holiday experience. As one of the few fully licensed European tour operators, we offer unlimited real-time travel combinations thanks to our proprietary Dynamic Holiday Packaging engine, providing additional customer protection and exclusive deals. lastminute.com N.V. is a publicly traded company listed under the ticker symbol, LMN on the SIX Swiss Exchange.
Media Contact:KMS Lighthouse [email protected] [email protected]://www.linkedin.com/company/kms-lighthouse/https://kmslh.com/

View original content:https://www.prnewswire.co.uk/news-releases/kms-lighthouse-and-lastminutecom-triumph-with-a-double-win-at-the-global-sourcing-association-gsa-2024-awards-302174249.html

Continue Reading

Artificial Intelligence

CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations

Published

on

cluepoints-continues-‘turning-artificial-intelligence-into-human-intelligence’-by-launching-two-new-innovations

Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
KING OF PRUSSIA, Pa., June 17, 2024 /PRNewswire/ — CluePoints, provider of leading statistical and AI-driven software solutions, will unveil two of its latest advanced, deep learning technology innovations at the DIA Global Annual Meeting 2024. Both solutions deliver groundbreaking enterprise platform transformations providing Sponsors and CROs with a smarter way to conduct clinical research and detect and manage risks that could impact clinical trial outcomes.

Taking RBQM to a new level, CluePoints’ Site Profile & Oversight Tool (SPOT) delivers adaptive site monitoring, enabling teams to swiftly pinpoint anomalies and translate insights into strategies and actions. Sponsors and CROs can improve their ability to evaluate the performance of clinical trial sites and adjust site visit plans more effectively and efficiently while accurately balancing risk and resource workload.
Further streamlining processes, CluePoints’ Intelligent Medical Coding solution harnesses advanced deep learning technology to enhance the accuracy and efficiency of coding in clinical trials. It seamlessly integrates with existing systems to offer precise, AI-generated coding suggestions, drastically reducing the need for manual dictionary searches and costly coding reviews, freeing up valuable resources and ensuring uniformity across all coded data.
Andy Cooper, CEO of CluePoints, said: “DIA offers the perfect opportunity to share with the industry our latest disruptive and innovative solutions that address key challenges within traditional clinical research methods. Unveiling two new products that leverage next generation AI will transform how CluePoints is viewed in the industry, as we enhance our enterprise-wide solutions to reach new levels of accuracy and efficiency to both improve clinical trial performance and deliver greater insights to further mitigate risk. Our early adopters are already raving about how valuable they are finding both product offerings and we are excited to showcase how they will shape future processes and embody our brand promise to ‘turn artificial intelligence into human intelligence.”
With over 9,500 users engaged with CluePoints’ enterprise platform, to date over 1,600 studies have been de-risked and over 142,000 issues detected.
Visitors to the CluePoints’ DIA Global exhibition booth #1301 will have the opportunity to meet with subject matter experts and see demonstrations of both new platform solutions.
CluePoints also invites DIA attendees to join them at 3pm on Tuesday, June 18th, for a special toast at their booth to celebrate the latest innovations.  
To learn more about CluePoints’ award-winning solutions, please visit www.cluepoints.com.
About CluePoints
CluePoints is the premier Risk-Based Quality Management (RBQM) and Data Quality Oversight Software provider. We are leveraging the potential of artificial intelligence using advanced statistics and machine learning to determine the quality, accuracy, and integrity of clinical trial data both during and after study conduct. Aligned with guidance from the FDA, EMA, and ICH E6 (R2), CluePoints is deployed to support central and on-site monitoring, medical review, quality risk management and to drive a holistic Risk-Based strategy in all trials. Coupled with thought leadership and consulting expertise to aid pre-study risk assessment, identification of risk controls and solution implementation, you now have everything you need to adhere with global regulatory guidance. The result is positive clinical development outcomes, increased operational efficiency, lower costs and reduced regulatory submission risk as part of the industry paradigm shift to RBQM.
 

View original content:https://www.prnewswire.co.uk/news-releases/cluepoints-continues-turning-artificial-intelligence-into-human-intelligence-by-launching-two-new-innovations-302174137.html

Continue Reading

Artificial Intelligence

ComplyCube Launches Trust Center with the Most Complete Compliance Posture in the Market

Published

on

complycube-launches-trust-center-with-the-most-complete-compliance-posture-in-the-market

LONDON, June 17, 2024 /PRNewswire/ — ComplyCube, a RegTech100 global leader in identity verification and compliance solutions, proudly announces the launch of its comprehensive Trust Center. This new initiative emphasizes ComplyCube’s unrivaled compliance posture, redefining security and privacy for IDV, KYC, and AML platforms. With over fifty continuously monitored controls, the AI-powered SaaS leads the way in ensuring clients stay ahead of international regulations and standards.

The Trust Center provides real-time updates on security measures, compliance statuses, and operational transparency, empowering clients to meet regulatory requirements confidently and allowing them to view ComplyCube’s compliance posture on demand. This platform is engineered to enhance transparency, build trust, and streamline compliance processes for organizations worldwide.
ComplyCube unveils its unrivaled compliance posture, redefining security and privacy for IDV, KYC, and AML platforms. With over fifty continuously monitored controls, ComplyCube leads the way in ensuring clients stay ahead of international regulations and standards.
Key Features of the Trust Center:
Real-Time Compliance Dashboard: Live updates on compliance metrics and security statuses.Comprehensive Resource Hub: Access to essential documents, certifications, and regulatory guidelines.Incident Reporting and Tracking: Full transparency in reporting and monitoring security incidents.Tarek Nechma, CEO of ComplyCube, remarked, “The launch of the Trust Center marks a pivotal milestone in our mission to build trust at scale and deliver state-of-the-art compliance solutions. This platform will empower our clients to navigate the complexities of regulatory landscapes with confidence.”
Non-compliance costs are 2.71 times higher than the costs of maintaining or meeting compliance requirements. Another study indicates that companies with strong compliance programs can reduce incident costs by up to 30%. On top of this, 84% of businesses encounter compliance challenges that can lead to significant financial and reputational damage. ComplyCube’s Trust Center aims to further mitigate these risks by providing tools that help businesses maintain and improve their compliance posture.
Mohamed Alsalehi, CTO of ComplyCube, stated, “We design our systems to be compliant by design with the stringent laws and regulations. This proactive approach ensures our clients can meet and exceed compliance requirements effortlessly.”
Joshua Dent, Business & Partnerships Manager, added, “The Trust Center showcases ComplyCube’s adherence to a multitude of globally recognized standards and data protection regulations. Clients and partners can find answers to many of their data protection questions, view active controls, and request documents to fulfill due diligence. It’s fantastic to see this go live following our latest certifications, such as UK DIATF, ISO 9001, PAD Level 2, and ISO 27001:2022 upgrade.”
ComplyCube continues to set industry standards with its innovative solutions, and the Trust Center’s launch underscores its mission to support businesses in achieving compliance excellence.
For more information about the Trust Center, visit ComplyCube Trust Center.
About ComplyCubeComplyCube is a leading provider of identity verification and compliance solutions, helping organizations across various sectors secure their operations and meet regulatory requirements. With a focus on innovation and customer satisfaction, ComplyCube delivers reliable and efficient services that empower businesses to thrive in a complex regulatory environment.
About VantaVanta is a leading trust management platform that automates compliance and streamlines security reviews for SaaS businesses. It helps companies manage risk and prove security in real-time, ensuring adherence to global standards and data protection regulations. With Vanta’s Trust Center, businesses can efficiently manage compliance processes and demonstrate their commitment to security and trust.
 
Photo: https://mma.prnewswire.com/media/2440210/Complycube_launches_trust_center.jpgLogo: https://mma.prnewswire.com/media/2148485/4765606/ComplyCube_Logo.jpg

View original content:https://www.prnewswire.co.uk/news-releases/complycube-launches-trust-center-with-the-most-complete-compliance-posture-in-the-market-302174177.html

Continue Reading
Advertisement
Stake.com
Advertisement

Latest News

Trending